As of September 30, the company had cash and cash equivalents of approximately $27.7M.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INMB:
- Inmune Bio to Host Q3 Results Conference Call
- INmune Bio CEO to Speak at Maxim Growth Summit
- Inmune Bio’s Promising Pipeline and Strategic Positioning Support Buy Rating Despite Recent Challenges
- Inmune Bio Submits Manuscript on Alzheimer’s Trial
- INmune Bio submits Phase 2 MINDFuL trial results to npj Dementia